PowerPoint · PDF fileReferences Goldfrank’s Toxicologic Emergencies, Tenth edition....

Post on 02-Mar-2018

260 views 5 download

transcript

Title Text

Heartbreakers

Michael Emswiler MD Division of Clinical Toxicology VCU Medical Center Virginia Poison Center

Objectives Physiology review Cardiac action potential Vaughn-Williams Classification

Discuss mechanism of selected toxins Beta-blockers CCB digoxin others

Discuss treatment options

Tox 101 Identify the patient Decontamination Antidote Enhanced elimination

Relevant anatomy

httpwwwtexasheartorgHICAnatomyanatomy2cfm

Myocytes Contractile cells Conducting cells SA node interatrial AV node bundle of His Purkinje fibers

httpswwwurmcrochestereduEncyclopediaGetImageaspxImageID=125477

We want action Action potentials are the same in the atria and

ventricles Long duration (when compared to skeletal muscle) Longer the AP ndash longer the refractory periods

Sinoatrial node action potential Automaticity ndash spontaneously generates action

potentials without neuronal input Unstable resting membrane potential No sustained plateau

Ventricular action potential

Costanzo Physiology 3rd edition 2006

Refractory period

httpswwwstudybluecomnotesnotenphysiology-cardiovascular-part-1deck4279768

Definitions Chronotropic-effects on HR Inotropic-effects on contractility Dromotropic-effects on conduction velocity

Back to the bedside P wave ndash represents atrial depolarization PR interval ndash represents AV node conduction QRS ndash depolarization of the ventricles T wave ndash repolarization of the ventricles QT interval ndash first ventricular depolarization to last

ventricular repolarization

Bringing it together

Text

httpwesleytoddblogspotcom201311action-potentialshtml

Vaughn-Williams Classification Class I Fast sodium channel blockers 1a Quinidine procainamide

1b Lidocaine phenytoin 1c Flecainide

Class I Beta blockers Propranolol esmolol metroprolol atenolol

Class III Potassium channel blockers Amiodarone Sotalol dofetilide Class IV Slow calcium channel blockers

Verapamil diltiazem

Class V Variable mechanism Adenosine Digoxin

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Heartbreakers

Michael Emswiler MD Division of Clinical Toxicology VCU Medical Center Virginia Poison Center

Objectives Physiology review Cardiac action potential Vaughn-Williams Classification

Discuss mechanism of selected toxins Beta-blockers CCB digoxin others

Discuss treatment options

Tox 101 Identify the patient Decontamination Antidote Enhanced elimination

Relevant anatomy

httpwwwtexasheartorgHICAnatomyanatomy2cfm

Myocytes Contractile cells Conducting cells SA node interatrial AV node bundle of His Purkinje fibers

httpswwwurmcrochestereduEncyclopediaGetImageaspxImageID=125477

We want action Action potentials are the same in the atria and

ventricles Long duration (when compared to skeletal muscle) Longer the AP ndash longer the refractory periods

Sinoatrial node action potential Automaticity ndash spontaneously generates action

potentials without neuronal input Unstable resting membrane potential No sustained plateau

Ventricular action potential

Costanzo Physiology 3rd edition 2006

Refractory period

httpswwwstudybluecomnotesnotenphysiology-cardiovascular-part-1deck4279768

Definitions Chronotropic-effects on HR Inotropic-effects on contractility Dromotropic-effects on conduction velocity

Back to the bedside P wave ndash represents atrial depolarization PR interval ndash represents AV node conduction QRS ndash depolarization of the ventricles T wave ndash repolarization of the ventricles QT interval ndash first ventricular depolarization to last

ventricular repolarization

Bringing it together

Text

httpwesleytoddblogspotcom201311action-potentialshtml

Vaughn-Williams Classification Class I Fast sodium channel blockers 1a Quinidine procainamide

1b Lidocaine phenytoin 1c Flecainide

Class I Beta blockers Propranolol esmolol metroprolol atenolol

Class III Potassium channel blockers Amiodarone Sotalol dofetilide Class IV Slow calcium channel blockers

Verapamil diltiazem

Class V Variable mechanism Adenosine Digoxin

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Objectives Physiology review Cardiac action potential Vaughn-Williams Classification

Discuss mechanism of selected toxins Beta-blockers CCB digoxin others

Discuss treatment options

Tox 101 Identify the patient Decontamination Antidote Enhanced elimination

Relevant anatomy

httpwwwtexasheartorgHICAnatomyanatomy2cfm

Myocytes Contractile cells Conducting cells SA node interatrial AV node bundle of His Purkinje fibers

httpswwwurmcrochestereduEncyclopediaGetImageaspxImageID=125477

We want action Action potentials are the same in the atria and

ventricles Long duration (when compared to skeletal muscle) Longer the AP ndash longer the refractory periods

Sinoatrial node action potential Automaticity ndash spontaneously generates action

potentials without neuronal input Unstable resting membrane potential No sustained plateau

Ventricular action potential

Costanzo Physiology 3rd edition 2006

Refractory period

httpswwwstudybluecomnotesnotenphysiology-cardiovascular-part-1deck4279768

Definitions Chronotropic-effects on HR Inotropic-effects on contractility Dromotropic-effects on conduction velocity

Back to the bedside P wave ndash represents atrial depolarization PR interval ndash represents AV node conduction QRS ndash depolarization of the ventricles T wave ndash repolarization of the ventricles QT interval ndash first ventricular depolarization to last

ventricular repolarization

Bringing it together

Text

httpwesleytoddblogspotcom201311action-potentialshtml

Vaughn-Williams Classification Class I Fast sodium channel blockers 1a Quinidine procainamide

1b Lidocaine phenytoin 1c Flecainide

Class I Beta blockers Propranolol esmolol metroprolol atenolol

Class III Potassium channel blockers Amiodarone Sotalol dofetilide Class IV Slow calcium channel blockers

Verapamil diltiazem

Class V Variable mechanism Adenosine Digoxin

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Tox 101 Identify the patient Decontamination Antidote Enhanced elimination

Relevant anatomy

httpwwwtexasheartorgHICAnatomyanatomy2cfm

Myocytes Contractile cells Conducting cells SA node interatrial AV node bundle of His Purkinje fibers

httpswwwurmcrochestereduEncyclopediaGetImageaspxImageID=125477

We want action Action potentials are the same in the atria and

ventricles Long duration (when compared to skeletal muscle) Longer the AP ndash longer the refractory periods

Sinoatrial node action potential Automaticity ndash spontaneously generates action

potentials without neuronal input Unstable resting membrane potential No sustained plateau

Ventricular action potential

Costanzo Physiology 3rd edition 2006

Refractory period

httpswwwstudybluecomnotesnotenphysiology-cardiovascular-part-1deck4279768

Definitions Chronotropic-effects on HR Inotropic-effects on contractility Dromotropic-effects on conduction velocity

Back to the bedside P wave ndash represents atrial depolarization PR interval ndash represents AV node conduction QRS ndash depolarization of the ventricles T wave ndash repolarization of the ventricles QT interval ndash first ventricular depolarization to last

ventricular repolarization

Bringing it together

Text

httpwesleytoddblogspotcom201311action-potentialshtml

Vaughn-Williams Classification Class I Fast sodium channel blockers 1a Quinidine procainamide

1b Lidocaine phenytoin 1c Flecainide

Class I Beta blockers Propranolol esmolol metroprolol atenolol

Class III Potassium channel blockers Amiodarone Sotalol dofetilide Class IV Slow calcium channel blockers

Verapamil diltiazem

Class V Variable mechanism Adenosine Digoxin

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Relevant anatomy

httpwwwtexasheartorgHICAnatomyanatomy2cfm

Myocytes Contractile cells Conducting cells SA node interatrial AV node bundle of His Purkinje fibers

httpswwwurmcrochestereduEncyclopediaGetImageaspxImageID=125477

We want action Action potentials are the same in the atria and

ventricles Long duration (when compared to skeletal muscle) Longer the AP ndash longer the refractory periods

Sinoatrial node action potential Automaticity ndash spontaneously generates action

potentials without neuronal input Unstable resting membrane potential No sustained plateau

Ventricular action potential

Costanzo Physiology 3rd edition 2006

Refractory period

httpswwwstudybluecomnotesnotenphysiology-cardiovascular-part-1deck4279768

Definitions Chronotropic-effects on HR Inotropic-effects on contractility Dromotropic-effects on conduction velocity

Back to the bedside P wave ndash represents atrial depolarization PR interval ndash represents AV node conduction QRS ndash depolarization of the ventricles T wave ndash repolarization of the ventricles QT interval ndash first ventricular depolarization to last

ventricular repolarization

Bringing it together

Text

httpwesleytoddblogspotcom201311action-potentialshtml

Vaughn-Williams Classification Class I Fast sodium channel blockers 1a Quinidine procainamide

1b Lidocaine phenytoin 1c Flecainide

Class I Beta blockers Propranolol esmolol metroprolol atenolol

Class III Potassium channel blockers Amiodarone Sotalol dofetilide Class IV Slow calcium channel blockers

Verapamil diltiazem

Class V Variable mechanism Adenosine Digoxin

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Myocytes Contractile cells Conducting cells SA node interatrial AV node bundle of His Purkinje fibers

httpswwwurmcrochestereduEncyclopediaGetImageaspxImageID=125477

We want action Action potentials are the same in the atria and

ventricles Long duration (when compared to skeletal muscle) Longer the AP ndash longer the refractory periods

Sinoatrial node action potential Automaticity ndash spontaneously generates action

potentials without neuronal input Unstable resting membrane potential No sustained plateau

Ventricular action potential

Costanzo Physiology 3rd edition 2006

Refractory period

httpswwwstudybluecomnotesnotenphysiology-cardiovascular-part-1deck4279768

Definitions Chronotropic-effects on HR Inotropic-effects on contractility Dromotropic-effects on conduction velocity

Back to the bedside P wave ndash represents atrial depolarization PR interval ndash represents AV node conduction QRS ndash depolarization of the ventricles T wave ndash repolarization of the ventricles QT interval ndash first ventricular depolarization to last

ventricular repolarization

Bringing it together

Text

httpwesleytoddblogspotcom201311action-potentialshtml

Vaughn-Williams Classification Class I Fast sodium channel blockers 1a Quinidine procainamide

1b Lidocaine phenytoin 1c Flecainide

Class I Beta blockers Propranolol esmolol metroprolol atenolol

Class III Potassium channel blockers Amiodarone Sotalol dofetilide Class IV Slow calcium channel blockers

Verapamil diltiazem

Class V Variable mechanism Adenosine Digoxin

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

We want action Action potentials are the same in the atria and

ventricles Long duration (when compared to skeletal muscle) Longer the AP ndash longer the refractory periods

Sinoatrial node action potential Automaticity ndash spontaneously generates action

potentials without neuronal input Unstable resting membrane potential No sustained plateau

Ventricular action potential

Costanzo Physiology 3rd edition 2006

Refractory period

httpswwwstudybluecomnotesnotenphysiology-cardiovascular-part-1deck4279768

Definitions Chronotropic-effects on HR Inotropic-effects on contractility Dromotropic-effects on conduction velocity

Back to the bedside P wave ndash represents atrial depolarization PR interval ndash represents AV node conduction QRS ndash depolarization of the ventricles T wave ndash repolarization of the ventricles QT interval ndash first ventricular depolarization to last

ventricular repolarization

Bringing it together

Text

httpwesleytoddblogspotcom201311action-potentialshtml

Vaughn-Williams Classification Class I Fast sodium channel blockers 1a Quinidine procainamide

1b Lidocaine phenytoin 1c Flecainide

Class I Beta blockers Propranolol esmolol metroprolol atenolol

Class III Potassium channel blockers Amiodarone Sotalol dofetilide Class IV Slow calcium channel blockers

Verapamil diltiazem

Class V Variable mechanism Adenosine Digoxin

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Sinoatrial node action potential Automaticity ndash spontaneously generates action

potentials without neuronal input Unstable resting membrane potential No sustained plateau

Ventricular action potential

Costanzo Physiology 3rd edition 2006

Refractory period

httpswwwstudybluecomnotesnotenphysiology-cardiovascular-part-1deck4279768

Definitions Chronotropic-effects on HR Inotropic-effects on contractility Dromotropic-effects on conduction velocity

Back to the bedside P wave ndash represents atrial depolarization PR interval ndash represents AV node conduction QRS ndash depolarization of the ventricles T wave ndash repolarization of the ventricles QT interval ndash first ventricular depolarization to last

ventricular repolarization

Bringing it together

Text

httpwesleytoddblogspotcom201311action-potentialshtml

Vaughn-Williams Classification Class I Fast sodium channel blockers 1a Quinidine procainamide

1b Lidocaine phenytoin 1c Flecainide

Class I Beta blockers Propranolol esmolol metroprolol atenolol

Class III Potassium channel blockers Amiodarone Sotalol dofetilide Class IV Slow calcium channel blockers

Verapamil diltiazem

Class V Variable mechanism Adenosine Digoxin

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Ventricular action potential

Costanzo Physiology 3rd edition 2006

Refractory period

httpswwwstudybluecomnotesnotenphysiology-cardiovascular-part-1deck4279768

Definitions Chronotropic-effects on HR Inotropic-effects on contractility Dromotropic-effects on conduction velocity

Back to the bedside P wave ndash represents atrial depolarization PR interval ndash represents AV node conduction QRS ndash depolarization of the ventricles T wave ndash repolarization of the ventricles QT interval ndash first ventricular depolarization to last

ventricular repolarization

Bringing it together

Text

httpwesleytoddblogspotcom201311action-potentialshtml

Vaughn-Williams Classification Class I Fast sodium channel blockers 1a Quinidine procainamide

1b Lidocaine phenytoin 1c Flecainide

Class I Beta blockers Propranolol esmolol metroprolol atenolol

Class III Potassium channel blockers Amiodarone Sotalol dofetilide Class IV Slow calcium channel blockers

Verapamil diltiazem

Class V Variable mechanism Adenosine Digoxin

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Refractory period

httpswwwstudybluecomnotesnotenphysiology-cardiovascular-part-1deck4279768

Definitions Chronotropic-effects on HR Inotropic-effects on contractility Dromotropic-effects on conduction velocity

Back to the bedside P wave ndash represents atrial depolarization PR interval ndash represents AV node conduction QRS ndash depolarization of the ventricles T wave ndash repolarization of the ventricles QT interval ndash first ventricular depolarization to last

ventricular repolarization

Bringing it together

Text

httpwesleytoddblogspotcom201311action-potentialshtml

Vaughn-Williams Classification Class I Fast sodium channel blockers 1a Quinidine procainamide

1b Lidocaine phenytoin 1c Flecainide

Class I Beta blockers Propranolol esmolol metroprolol atenolol

Class III Potassium channel blockers Amiodarone Sotalol dofetilide Class IV Slow calcium channel blockers

Verapamil diltiazem

Class V Variable mechanism Adenosine Digoxin

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Definitions Chronotropic-effects on HR Inotropic-effects on contractility Dromotropic-effects on conduction velocity

Back to the bedside P wave ndash represents atrial depolarization PR interval ndash represents AV node conduction QRS ndash depolarization of the ventricles T wave ndash repolarization of the ventricles QT interval ndash first ventricular depolarization to last

ventricular repolarization

Bringing it together

Text

httpwesleytoddblogspotcom201311action-potentialshtml

Vaughn-Williams Classification Class I Fast sodium channel blockers 1a Quinidine procainamide

1b Lidocaine phenytoin 1c Flecainide

Class I Beta blockers Propranolol esmolol metroprolol atenolol

Class III Potassium channel blockers Amiodarone Sotalol dofetilide Class IV Slow calcium channel blockers

Verapamil diltiazem

Class V Variable mechanism Adenosine Digoxin

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Back to the bedside P wave ndash represents atrial depolarization PR interval ndash represents AV node conduction QRS ndash depolarization of the ventricles T wave ndash repolarization of the ventricles QT interval ndash first ventricular depolarization to last

ventricular repolarization

Bringing it together

Text

httpwesleytoddblogspotcom201311action-potentialshtml

Vaughn-Williams Classification Class I Fast sodium channel blockers 1a Quinidine procainamide

1b Lidocaine phenytoin 1c Flecainide

Class I Beta blockers Propranolol esmolol metroprolol atenolol

Class III Potassium channel blockers Amiodarone Sotalol dofetilide Class IV Slow calcium channel blockers

Verapamil diltiazem

Class V Variable mechanism Adenosine Digoxin

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Bringing it together

Text

httpwesleytoddblogspotcom201311action-potentialshtml

Vaughn-Williams Classification Class I Fast sodium channel blockers 1a Quinidine procainamide

1b Lidocaine phenytoin 1c Flecainide

Class I Beta blockers Propranolol esmolol metroprolol atenolol

Class III Potassium channel blockers Amiodarone Sotalol dofetilide Class IV Slow calcium channel blockers

Verapamil diltiazem

Class V Variable mechanism Adenosine Digoxin

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Vaughn-Williams Classification Class I Fast sodium channel blockers 1a Quinidine procainamide

1b Lidocaine phenytoin 1c Flecainide

Class I Beta blockers Propranolol esmolol metroprolol atenolol

Class III Potassium channel blockers Amiodarone Sotalol dofetilide Class IV Slow calcium channel blockers

Verapamil diltiazem

Class V Variable mechanism Adenosine Digoxin

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Lastly where does BP come from BP = CO x PVR CO = SV x HR

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Letrsquos review Pacemaker cells with automaticity Different action potential

Atria and ventricles have prolonged action potential Work together to function as a syncyticum Electrolytes are critically important to normal function

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Beta blockers

Properties of β-adrenergic receptor blockers

Drug Cardioselectivity Lipophilicity Protein Binding Intrinsic sympathomimetic activity Membrane Stabilizing Effect

Time to peak plasma concentration (hours)

Elimination t frac12 (hours)

Acebutolol β1 Low 25 Yes Yes 2-4 2-4

Atenolol β1 Low lt5 No No 2-4 5-8

Carvedilol β1β2α1 High 95-98 No Yes 1-2 6-10

Labetalol β1β2α1 Low-moderate 50 No No 1-2 8

Metoprolol β1 Moderate 10 No No 15-2 3-4

Nadolol β1β2 Low 30 No No 3-4 10-20

Nebivolol β1 High 98 No No 15-4 12-19

Propranolol β1β2 High 90 No Yes 1-2 3-5

Sotalol β1β2 Low 0 No No 204 10-20

Timolol β1β2 Low-moderate lt10 No No 1-2 2-4

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Beta receptors Beta receptors are located

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Beta blockers

Certainly good in therapeutic doses Buthellip

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Beta blockers Can be life threatening in overdose

Who needs treatment

And how do you treat them

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Identifying potential adverse reactions Children

Individuals with suspicion for self-harm

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Treatment Consider GI decontamination

Two large bore Ivs

Crystalloid IVF

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Treatment What else are you going to do

What pressor(s) are available to you

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Any other therapies IVF calcium glucagon IV

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Goldfrankrsquos Toxicologic Emergencies 10th edition

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Any other therapies Hyperinsulinemia-euglycemia

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Calcium channel blockers Where are they located Heart nerves pancreas muscles

Primarily antagonize (block) L-type Calcium channels

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

CCB

Class Specific drugs Phenylalkylamine Verapamil Benzothiazepine Diltiazem Dihydropyridines Amlodipine

Clevidipine Felodipine Isradipine Nicardipine Nifedipine Nimodipine Nisoldipine

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

CCB While the mechanism seems clear

In overdose ndash you lose specificity

May also see hyperglycemia

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Clinical presentation Hypotension and bradycardia

Fatigue dizziness AMS

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Treatment Consider GI decontamination

Two large bore IVs

Crystalloid IVF

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Pharmacologic treatment Atropine Calcium Glucagon

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Pharmacologic treatment Pressors HIE Intralipid

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Pharmacologic treatment Intralipid

wwwthepoisonreviewcom

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Digoxin Well known mechanism Characteristic EKG findings Narrow therapeutic index

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Digoxin

httplifeinthefastlanecomecg-librarydigoxin-effect

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Digoxoin Cause Treatment Antidote

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Next case 28 yo male present with altered mental status after

performing poorly on his semester grades Has seemed depressed to his roommates over the past few days

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Treatment Text

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

TCA Text

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

TCA Pharmacology SNRI Antimuscarinic H1 Antagonist Alpha 1 antagonist Fast Na Ch blockade 1A effect

Clincal effect Seizures Anticholinergic sxs Sedation Hypotension Cardiotoxicity

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Itrsquos widehellipand itrsquos tox Na channel blockers TCAs Diphenhydramine Venlafaxine

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

QT prolongation

Definition Inherited causes Medications

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

QT prolongation - Medications

Amiodarone Dofetilide Procainamide Sotalol Chloroquine Chlorpromazine Haloperidol

Methadone Droperidol

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Whatrsquos the problem with a little QT Torsade de pointes ndash twisting of the points

httpmstcparamedicpbworkscomwpage21902876Torsades20de20Pointes

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

The most common cardiac toxin

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Hyperkalemia Most commonly AKI or ESRD But really anything that either Increases absorption (increased intake) Decreased excretion (AKI medications etc)

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Hyperkalemia Text

httplifeinthefastlanecomecg-librarybasicshyperkalaemia

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

References Goldfrankrsquos Toxicologic Emergencies Tenth edition 2015

Rosenrsquos Emergency Medicine Seventh edition

Charlotte van Noord12 Mark Eijgelsheim1 and Bruno H Ch Strickerr Drug- and non-drug-associated QT interval prolongation Br J Clin Pharmacol 2010 Jul 70(1) 16ndash23

Drug-Induced Prolongation of the QT Interval

Roden D Drug-Induced Prolongation of the QT interval NEJM 2004 3501013-1022 2004

Evans KJ1 Greenberg A Hyperkalemia a review J Intensive Care Med 2005 Sep-Oct20(5)272-90

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere

Questions Call anytime anywhere

  • Title
  • Heartbreakers
  • Objectives
  • Tox 101
  • Slide Number 5
  • Slide Number 6
  • Relevant anatomy
  • Myocytes
  • We want action
  • Sinoatrial node action potential
  • Ventricular action potential
  • Refractory period
  • Definitions
  • Back to the bedside
  • Bringing it together
  • Slide Number 16
  • Lastly where does BP come from
  • Letrsquos review
  • Beta blockers
  • Beta receptors
  • Beta blockers
  • Beta blockers
  • Identifying potential adverse reactions
  • Treatment
  • Treatment
  • Any other therapies
  • Any other therapies
  • Calcium channel blockers
  • CCB
  • CCB
  • Clinical presentation
  • Treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Pharmacologic treatment
  • Digoxin
  • Digoxin
  • Digoxoin
  • Next case
  • Treatment
  • TCA
  • TCA
  • Itrsquos widehellipand itrsquos tox
  • QT prolongation
  • QT prolongation - Medications
  • Whatrsquos the problem with a little QT
  • The most common cardiac toxin
  • Hyperkalemia
  • Hyperkalemia
  • Hyperkalemia
  • Slide Number 52
  • Slide Number 53
  • References
  • Questions Call anytime anywhere